Rafferty Asset Management »

Zenas Biopharma shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $942k 48k 19.55

More positions owned by Rafferty Asset Management

Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Micron Technology (MU)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Ishares Msci Sth Kor Etf (EWY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Applied Materials (AMAT)
Apple (AAPL)
Microsoft Corporation (MSFT)
Marvell Technology (MRVL)
Ishares Tr China Lg-cap Etf (FXI)
Intel Corporation (INTC)

View all positions for Rafferty Asset Management

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
Polar Capital Holdings
Capital Research and Management Company - Division 3
Fairmount Funds Management
BlackRock
NVP Associates
State Street Corporation
Wellington Management Company
Vanguard Capital Management
Silverarc Capital Management
Alliancebernstein

View all funds holding Zenas Biopharma